<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00631904</url>
  </required_header>
  <id_info>
    <org_study_id>010503</org_study_id>
    <nct_id>NCT00631904</nct_id>
  </id_info>
  <brief_title>St. Mary's Duluth Clinic (SMDC) Pacemaker Magnetic Resonance Imaging (MRI) Study</brief_title>
  <official_title>SMDC Pacemaker-MRI Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Essentia Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Essentia Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to monitor and follow non-pacemaker dependent patients with
      implanted permanent pacemakers, who undergo medically required Magnetic Resonance Imaging
      (MRI) scans.

      Patients with pacemakers are currently excluded from obtaining MRI scans. MRI scanning is now
      the imaging of choice for a number of neurological, vascular, or musculoskeletal conditions.

      Data suggests that patients with pacemakers, when properly monitored, can safely undergo MRI
      scanning, though the largest published study to date consists of 54 patients, and no long
      term follow-up has been published.

      Though MRI cardiac scanning has been demonstrated to produce local tissue heating at the
      pacemaker lead tip, the long term effect of tissue heating on lead stability is unclear.

      This study will evaluate patients with permanent pacemakers undergoing medically indicated
      MRI scanning.

      Patients will be followed for one year at 3, 6, and 12 months. Data collected will evaluate
      change in pacing thresholds over time as well as cardiac troponin I, creatinine kinase MB
      function, and myoglobin levels within the first 12 hours following the scans, side effects,
      symptoms, the need to make pacemaker program changes, and possible artifacts created by the
      pacemaker on the MRI scan.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Any change greater than 1 volt at a pulse width of 0.5 ms in a pacemaker lead 12 months from an MRI scan</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac troponin-I, creatine kinase, MB fraction, and myoglobin levels within the first 12 hours following the scans.</measure>
    <time_frame>12 hours</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">150</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Single Observation</arm_group_label>
    <description>Patients with permanent pacemakers undergoing medically indicated MRI scanning.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Permanent pacemaker or implantable cardioverter-defibrillator (ICD) implanted for at least
        6 weeks.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Permanent pacemaker or ICD implanted for at least 6 weeks

          -  Referred for medically indicated MRI

          -  Age greater or equal to 18 years old

        Exclusion Criteria:

          -  ICD market released before 2001 including GDT Ventak-AV, GDT MINI-II, GDT MINI-IV, GDT
             MINI-III, GDT Prizm-2 MDT GEM-I series

          -  Epicardial coronary sinus lead or subcutaneous array

          -  Unable to program all leads to bipolar configuration

          -  Pacemaker Dependent

          -  Device has reached elective replacement or end of life

          -  Other usual contraindications to MRI scanning

          -  The use of inotropic pharmacological agents, such as dobutamine, during the MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Mollerus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Essentia Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Essentia Health</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Erlebacher JA, Cahill PT, Pannizzo F, Knowles RJ. Effect of magnetic resonance imaging on DDD pacemakers. Am J Cardiol. 1986 Feb 15;57(6):437-40.</citation>
    <PMID>3946261</PMID>
  </reference>
  <reference>
    <citation>Sommer T, Vahlhaus C, Lauck G, von Smekal A, Reinke M, Hofer U, Block W, Tr√§ber F, Schneider C, Gieseke J, Jung W, Schild H. MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology. 2000 Jun;215(3):869-79.</citation>
    <PMID>10831713</PMID>
  </reference>
  <reference>
    <citation>Shellock FG, O'Neil M, Ivans V, Kelly D, O'Connor M, Toay L, Crues JV. Cardiac pacemakers and implantable cardioverter defibrillators are unaffected by operation of an extremity MR imaging system. AJR Am J Roentgenol. 1999 Jan;172(1):165-70.</citation>
    <PMID>9888762</PMID>
  </reference>
  <reference>
    <citation>Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfeld TM, Bluemke DA, Lardo A, Berger RD, Calkins H, Halperin HR. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation. 2004 Aug 3;110(5):475-82. Epub 2004 Jul 26.</citation>
    <PMID>15277324</PMID>
  </reference>
  <reference>
    <citation>Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, Weiss RG, Berger RD, Bluemke DA, Halperin HR. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation. 2006 Sep 19;114(12):1277-84. Epub 2006 Sep 11.</citation>
    <PMID>16966586</PMID>
  </reference>
  <reference>
    <citation>Gimbel JR, Bailey SM, Tchou PJ, Ruggieri PM, Wilkoff BL. Strategies for the safe magnetic resonance imaging of pacemaker-dependent patients. Pacing Clin Electrophysiol. 2005 Oct;28(10):1041-6.</citation>
    <PMID>16221260</PMID>
  </reference>
  <reference>
    <citation>Hayes DL, Holmes DR Jr, Gray JE. Effect of 1.5 tesla nuclear magnetic resonance imaging scanner on implanted permanent pacemakers. J Am Coll Cardiol. 1987 Oct;10(4):782-6.</citation>
    <PMID>3655146</PMID>
  </reference>
  <reference>
    <citation>Goldschlager N, Epstein A, Friedman P, Gang E, Krol R, Olshansky B; North American Society of Pacing and Electrophysiology (NASPE) Practice Guideline Committee. Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatment. Arch Intern Med. 2001 Mar 12;161(5):649-55. Review.</citation>
    <PMID>11231696</PMID>
  </reference>
  <reference>
    <citation>Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol. 2004 Apr 7;43(7):1315-24.</citation>
    <PMID>15063447</PMID>
  </reference>
  <reference>
    <citation>Fetter J, Aram G, Holmes DR Jr, Gray JE, Hayes DL. The effects of nuclear magnetic resonance imagers on external and implantable pulse generators. Pacing Clin Electrophysiol. 1984 Jul;7(4):720-7.</citation>
    <PMID>6205375</PMID>
  </reference>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 29, 2008</study_first_submitted>
  <study_first_submitted_qc>March 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2008</study_first_posted>
  <last_update_submitted>August 31, 2011</last_update_submitted>
  <last_update_submitted_qc>August 31, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Michael Mollerus, MD</name_title>
    <organization>Essentia Health</organization>
  </responsible_party>
  <keyword>Pacemaker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

